Tapewire

NYSE · USD

NRXS

Neuraxis, INC

Export transactions ↓
Tapewire entity
6994
SEC CIK
0001933567
Parsed reports
61

Last 12 months

Inside the activity.

9 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202510
Jan 202600
Feb 202620
Mar 202600
Apr 202630
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202630

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 04, 2025 Filed Sep 10, 2025 10:32 UTC
Carrico Brian AllenDirector · Chief Executive Officer
GrantRSU · Derivative 90,640 $2.18 $197,595.20
Disclosure

SEC source: 0001641172-25-027017 · ownership.xml · derivative · entry 2

Carrico Brian Allen · CIK 0001959279 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,640

Underlying: Common Stock · 90,640 shares

Expires not disclosed

F2 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F2 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F2 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

Read SEC document
March 04, 2025 Filed Sep 10, 2025 10:32 UTC
Carrico Brian AllenDirector · Chief Executive Officer
GrantRSU · Derivative 10,000 $2.18 $21,800.00
Disclosure

SEC source: 0001641172-25-027017 · ownership.xml · derivative · entry 1

Carrico Brian Allen · CIK 0001959279 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F1 · derivative.exercise_price: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

F1 · derivative.exercise_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

F1 · derivative.expiration_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

Read SEC document
March 04, 2025 Filed Sep 10, 2025 10:32 UTC
Miranda AdrianCMO, SVP Science & Tech
GrantRSU · Derivative 30,000 $2.18 $65,400.00
Disclosure

SEC source: 0001641172-25-027022 · ownership.xml · derivative · entry 2

Miranda Adrian · CIK 0001992525 · CMO, SVP Science & Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F2 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F2 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

Read SEC document
March 04, 2025 Filed Sep 10, 2025 10:32 UTC
Miranda AdrianCMO, SVP Science & Tech
GrantRSU · Derivative 10,000 $2.18 $21,800.00
Disclosure

SEC source: 0001641172-25-027022 · ownership.xml · derivative · entry 1

Miranda Adrian · CIK 0001992525 · CMO, SVP Science & Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F1 · derivative.exercise_price: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

F1 · derivative.exercise_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

F1 · derivative.expiration_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

Read SEC document
March 04, 2025 Filed Sep 10, 2025 10:32 UTC GrantRSU · Derivative 27,435 $2.18 $59,808.30
Disclosure

SEC source: 0001641172-25-027018 · ownership.xml · derivative · entry 2

Carrico Thomas Joeseph · CIK 0001959325 · CRO, CCO, CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,435

Underlying: Common Stock · 27,435 shares

Expires not disclosed

F2 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F2 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F2 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

Read SEC document
March 04, 2025 Filed Sep 10, 2025 10:32 UTC GrantRSU · Derivative 10,000 $2.18 $21,800.00
Disclosure

SEC source: 0001641172-25-027018 · ownership.xml · derivative · entry 1

Carrico Thomas Joeseph · CIK 0001959325 · CRO, CCO, CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F1 · derivative.exercise_price: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

F1 · derivative.exercise_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

F1 · derivative.expiration_date: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.

Read SEC document
January 17, 2025 Filed Sep 10, 2025 10:32 UTC GrantCommon Stock 13,157 $2.85 $37,497.45
Disclosure

SEC source: 0001641172-25-027021 · ownership.xml · nonDerivative · entry 1

Keyser Jane Elizabeth · CIK 0001959756 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,737

F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

Read SEC document
January 17, 2025 Filed Sep 10, 2025 10:32 UTC GrantCommon Stock 13,157 $2.85 $37,497.45
Disclosure

SEC source: 0001641172-25-027019 · ownership.xml · nonDerivative · entry 1

Ferge Kristin A · CIK 0001343345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,340

F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

Read SEC document
January 17, 2025 Filed Sep 10, 2025 10:32 UTC GrantCommon Stock 13,157 $2.85 $37,497.45
Disclosure

SEC source: 0001641172-25-027023 · ownership.xml · nonDerivative · entry 1

Watkins Bradley Mitchell · CIK 0001959534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,737

F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

Read SEC document
January 03, 2025 Filed Sep 10, 2025 10:32 UTC
Henrichs Timothy RobertChief Financial Officer
GrantRSU · Derivative 67,980 $2.42 $164,511.60
Disclosure

SEC source: 0001641172-25-027020 · ownership.xml · derivative · entry 4

Henrichs Timothy Robert · CIK 0001959954 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,980

Underlying: Common Stock · 67,980 shares

Expires not disclosed

F4 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F4 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F4 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

Read SEC document
January 03, 2025 Filed Sep 10, 2025 10:32 UTC
Carrico Brian AllenDirector · Chief Executive Officer
GrantRSU · Derivative 70,019 $2.42 $169,445.98
Disclosure

SEC source: 0001641172-25-027017 · ownership.xml · derivative · entry 3

Carrico Brian Allen · CIK 0001959279 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,019

Underlying: Common Stock · 70,019 shares

Expires not disclosed

F3 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F3 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F3 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

Read SEC document
January 03, 2025 Filed Sep 10, 2025 10:32 UTC
Miranda AdrianCMO, SVP Science & Tech
GrantRSU · Derivative 35,000 $2.42 $84,700.00
Disclosure

SEC source: 0001641172-25-027022 · ownership.xml · derivative · entry 3

Miranda Adrian · CIK 0001992525 · CMO, SVP Science & Tech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires not disclosed

F3 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F3 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F3 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

Read SEC document
January 03, 2025 Filed Sep 10, 2025 10:32 UTC GrantRSU · Derivative 35,000 $2.42 $84,700.00
Disclosure

SEC source: 0001641172-25-027018 · ownership.xml · derivative · entry 3

Carrico Thomas Joeseph · CIK 0001959325 · CRO, CCO, CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires not disclosed

F3 · derivative.exercise_price: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F3 · derivative.exercise_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

F3 · derivative.expiration_date: These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 19:16 UTC GrantCommon Stock, par value $0.001 11,580 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-025970 · ownership.xml · nonDerivative · entry 1

Keyser Jane Elizabeth · CIK 0001959756 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,580

F1 · kind: These shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), were issued to Ms. Keyser pursuant to an Unrestricted Stock Award Agreement dated June 28, 2024 (the "Agreement"), by and between NeurAxis, Inc. (the "Company") and Ms. Keyser. Pursuant to the Agreement, as compensation for the services provided as a member of the Board of Directors of the Company by Ms. Keyser through March 31, 2024, the Company issued Ms. Keyser the number of shares of Common Stock as determined by dividing $32,191.78 by the closing price of the Common Stock on June 28, 2024, which was $2.78 per share.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 19:18 UTC GrantCommon Stock, par value $0.001 1,183 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-025972 · ownership.xml · nonDerivative · entry 1

Ferge Kristin A · CIK 0001343345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,183

F1 · kind: These shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), were issued to Ms. Ferge pursuant to an Unrestricted Stock Award Agreement dated June 28, 2024 (the "Agreement"), by and between NeurAxis, Inc. (the "Company") and Ms. Ferge. Pursuant to the Agreement, as compensation for the services provided as a member of the Board of Directors of the Company by Ms. Ferge through March 31, 2024, the Company issued Ms. Ferge the number of shares of Common Stock as determined by dividing $3,287.67 by the closing price of the Common Stock on June 28, 2024, which was $2.78 per share.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 19:13 UTC GrantCommon Stock, par value $0.001 11,580 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-025968 · ownership.xml · nonDerivative · entry 1

Watkins Bradley Mitchell · CIK 0001959534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,580

F1 · kind: These shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), were issued to Mr. Watkins pursuant to an Unrestricted Stock Award Agreement dated June 28, 2024 (the "Agreement"), by and between NeurAxis, Inc. (the "Company") and Mr. Watkins. Pursuant to the Agreement, as compensation for the services provided as a member of the Board of Directors of the Company by Mr. Watkins through March 31, 2024, the Company issued Mr. Watkins the number of shares of Common Stock as determined by dividing $32,191.78 by the closing price of the Common Stock on June 28, 2024, which was $2.78 per share.

Read SEC document
February 20, 2024 Filed Feb 29, 2024 15:14 UTC GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-006005 · rdgdoc.xml · nonDerivative · entry 1

Hannasch Brian · CIK 0001911504 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 757,901

F1 · kind: On February 20, 2024, the reporting person received 75,000 shares of common stock of Neuraxis, Inc. pursuant to the terms of a Consulting Agreement dated December 27, 2023.

Read SEC document
February 06, 2024 Filed Feb 14, 2024 21:30 UTC OtherCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-004168 · rdgdoc.xml · nonDerivative · entry 1

Hannasch Brian · CIK 0001911504 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 682,901

F1 · kind: On February 6, 2024, the reporting person received an aggregate of 150,000 shares of Neuraxis, Inc. (the "Company") common stock from directors and officers of the Company pursuant to the terms of a promissory note dated August 1, 2023.

Read SEC document
December 28, 2023 Filed Jan 23, 2024 21:06 UTC OtherWarrant (right to purchase) · Derivative 40,000 $0.00 Strike: $0.01 $0.00
Disclosure

SEC source: 0001437749-24-001951 · rdgdoc.xml · derivative · entry 3

Hannasch Brian · CIK 0001911504 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2029-09-06

Read SEC document
December 28, 2023 Filed Jan 23, 2024 21:06 UTC SaleCommon Stock 76 $2.61 $198.36
Disclosure

SEC source: 0001437749-24-001951 · rdgdoc.xml · nonDerivative · entry 2

Hannasch Brian · CIK 0001911504 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 532,901

F1 · kind: On December 28, 2023, the reporting person exercised a warrant to purchase 40,000 shares of Neuraxis, Inc. (the "Company") common stock for $0.005 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company withholding 76 of the warrant shares to pay the exercise price and issuing the reporting person the remaining 39,924 shares.

Read SEC document
December 28, 2023 Filed Jan 23, 2024 21:06 UTC OtherCommon Stock 40,000 $0.01 $200.00
Disclosure

SEC source: 0001437749-24-001951 · rdgdoc.xml · nonDerivative · entry 1

Hannasch Brian · CIK 0001911504 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 532,977

Read SEC document
August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment
MASIMO CORP10% owner
ConversionPre-Funded Warrant, Common Stock (Right to Buy) · Derivative 289,779 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · derivative · entry 4

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,779

Underlying: Common Stock · 289,779 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment
MASIMO CORP10% owner
ConversionPre-Funded Warrant, Series A Preferred Stock (Right to Buy) · Derivative 144,890 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · derivative · entry 3

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Preferred Stock · 144,890 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

F2 · derivative.underlying_shares: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment
MASIMO CORP10% owner
ConversionSeries A Preferred Stock · Derivative 265,774 $0.00 $0.00
Disclosure

SEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · derivative · entry 2

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 531,548 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

F1 · derivative.underlying_shares: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

Read SEC document
August 11, 2023 Filed Aug 11, 2023 23:42 UTC Amendment
MASIMO CORP10% owner
ConversionCommon Stock 531,548 Not disclosed Not disclosed
Disclosure

SEC source: 0000937556-23-000202 · wf-form4a_169179734438990.xml · nonDerivative · entry 1

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 531,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

Read SEC document
August 10, 2023 Filed Aug 10, 2023 21:16 UTC
MASIMO CORP10% owner
ConversionPre-Funded Warrant, Common Stock (Right to Buy) · Derivative 289,779 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · derivative · entry 4

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,779

Underlying: Common Stock · 289,779 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

Read SEC document
August 10, 2023 Filed Aug 10, 2023 21:16 UTC
MASIMO CORP10% owner
ConversionPre-Funded Warrant, Series A Preferred Stock (Right to Buy) · Derivative 144,890 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · derivative · entry 3

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Preferred Stock · 144,890 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

F2 · derivative.expiration_date: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

F2 · derivative.underlying_shares: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.

Read SEC document
August 10, 2023 Filed Aug 10, 2023 21:16 UTC
MASIMO CORP10% owner
ConversionSeries A Preferred Stock · Derivative 265,774 $0.00 $0.00
Disclosure

SEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · derivative · entry 2

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 531,548 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

F1 · derivative.underlying_shares: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

Read SEC document
August 10, 2023 Filed Aug 10, 2023 21:16 UTC
MASIMO CORP10% owner
ConversionCommon Stock 531,548 Not disclosed Not disclosed
Disclosure

SEC source: 0000937556-23-000199 · wf-form4_169170219111216.xml · nonDerivative · entry 1

MASIMO CORP · CIK 0000937556 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 531,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.